All systems operational
For Researchers For Publishers Login Register
Home Authors Usama Gergis
UG

Usama Gergis

h-4 H-Index
110 Citations
9 Papers

Published Papers

9 indexed
1
The Risk and Prognosis of COVID-19 Infection in Cancer Patients
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.07.005
80 citations 397
2
Next-Generation Chimeric Antigen Receptor T-cells
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1035
11 citations 386
3
Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1030
5 citations 388
4
Ofatumumab for Post-Transplant Lymphoproliferative Disorder
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.04.004
4 citations 391
5
Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System Involvement
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1024
4 citations 388
6
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1062
4 citations 389
7
Chimeric Antigen Receptor T Cell Therapy For Solid Tumors
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1028
2 citations 389
8
The Two-Step Allogeneic Stem Cell Transplant Is Associated with Excellent Engraftment, Improved Survival and Low Nonrelapse Mortality in Patients with Myelofibrosis
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-25-00039
0 citations 388
9
From Spirometry to Survival: Ambiguities in Pulmonary Metrics for Cellular Therapy Outcomes
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-26-00026
0 citations 386

Publication Activity

Journals Published In

Hematology/Oncology and Stem Cell Therapy
🇸🇦 Q3 AMS 72